At a glance
The March 8, 2021, Clinical Laboratory COVID-19 Response (CLCR) call included updates on SARS-CoV-2 variants and from the FDA and CDC Infectious Diseases Pathology Branch.

Agenda
Welcome: Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
SARS-CoV-2 Variants Update: Vivien Dugan, CDC Laboratory and Testing Task Force for the COVID-19 Response
Updates from the CDC Infectious Diseases Pathology Branch: Julu Bhatnagar, CDC Division of High-Consequence Pathogens and Pathology (DCHPP)
FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)